drugset / Trial / NCT02051790

Evaluation of Reader Training Processes

NCT02051790

Phase 4 Completed 241 enrolled Avid Radiopharmaceuticals
Non-randomizedSingle-groupSingle-blindDiagnostic

Summary

This study is designed to evaluate the agreement between florbetapir F 18 scan interpretation in the clinic and by expert readers.

Timeline

Start
2014-03
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject florbetapir F 18 Diagnostic / imaging agent

Indications